2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Personality Disorders: new trials by email Literature Review of Personality Disorders trials Research Report on Personality Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order naratriptan, placebo - Psychotic Disorders, Antisocial Personality Disorder | Phase 4 | Terminated | UMC Utrecht | 8 | 2006-11-01 | 2015-01-26 |
| Pharmacology of Cognition in Schizotypal Personality Disorder Guanfacine, Placebo - Schizotypal Personality Disorder, Personality Disorders | Phase 4 | Terminated | Icahn School of Medicine at Mount Sinai | 29 | 1995-09-01 | 2017-02-10 |
Antisocial Personality Disorder (1) · Disruptive, Impulse Control, and Conduct Disorders (1) · Psychotic Disorders (1) · Schizotypal Personality Disorder (1)
Mental Disorders (2) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Guanfacine (1) · naratriptan (1)
Icahn School of Medicine at Mount Sinai (1) · UMC Utrecht (1)
Netherlands (1) · United States (1)
Adriano van der Loo, MD (1) · Berend Olivier, PhD (1) · Frank Koerselman, MD, PhD (1) · Henk Nijman, PhD (1) · Larry J. Siever, MD (1) · Rob L. van Ojen, MD, PhD (1)
R01MH056140 (1)